Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 31 citing articles:

ApoB100 and Atherosclerosis: What’s New in the 21st Century?
Dimitris Kounatidis, Natalia G. Vallianou, Aikaterini Poulaki, et al.
Metabolites (2024) Vol. 14, Iss. 2, pp. 123-123
Open Access | Times Cited: 15
2024 Guidelines of the Polish Society of Laboratory Diagnostics and the Polish Lipid Association on laboratory diagnostics of lipid metabolism disorders.
Bogdan Solnica, Grażyna Sygitowicz, Dariusz Sitkiewicz, et al.
Archives of Medical Science (2024)
Open Access | Times Cited: 9
2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP)
Maciej Banach, Željko Reiner, Stanisław Surma, et al.
Drugs (2024)
Open Access | Times Cited: 9
Whether and Why Do We Need a Vaccine Against Atherosclerosis? Can We Expect It Anytime Soon?
Stanisław Surma, Amirhossein Sahebkar, Maciej Banach
Current Atherosclerosis Reports (2024)
Open Access | Times Cited: 6
Lipoprotein apheresis affects the concentration of extracellular vesicles in patients with elevated lipoprotein (a)
Joanna Marlęga-Linert, Aleksandra Gąsecka, Edwin van der Pol, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Monitoring of traditional atherosclerosis cardiovascular disease risk factors - is it enough to prevent premature acute coronary syndrome?
Maciej Banach, Stanisław Surma
The Lancet Regional Health - Europe (2024) Vol. 38, pp. 100866-100866
Open Access | Times Cited: 5
Omega-3 (n-3) Fatty Acid–Statin Interaction: Evidence for a Novel Therapeutic Strategy for Atherosclerotic Cardiovascular Disease
Ivana Djuričić, Philip C. Calder
Nutrients (2024) Vol. 16, Iss. 7, pp. 962-962
Open Access | Times Cited: 4
Uso de nuevas terapias hipolipemiantes en la práctica clínica. Consenso SEC/SEA/SEEN/SEMFYC/SEMERGEN/SEMG/SEN/SEACV/S.E.N.
David Vivas, Carlos Escobar, Alberto Cordero, et al.
REC CardioClinics (2024) Vol. 59, Iss. 4, pp. 310-321
Closed Access | Times Cited: 4
Prolonged Hospital Stay in Hypertensive Patients: Retrospective Analysis of Risk Factors and Interactions
Stanisław Surma, Michał Czapla, Izabella Uchmanowicz, et al.
Nursing Reports (2025) Vol. 15, Iss. 3, pp. 110-110
Open Access
Impact of Lipid-Lowering Combination Therapy With Statins and Ezetimibe vs Statin Monotherapy on the Reduction of Cardiovascular Outcomes: A Meta-analysis
Maciej Banach, Vikash Jaiswal, Song Peng Ang, et al.
Mayo Clinic Proceedings (2025)
Closed Access
Nanotechnology-Based Management of Cardiovascular Disease
Shubhrat Maheshwari, Amita Verma, Aditya Singh, et al.
(2025), pp. 235-250
Closed Access
A Scoring Model Using Multi-Metabolites Based on Untargeted Metabolomics for Assessing Dyslipidemia in Korean Individuals with Obesity
Su‐Geun Yang, Hye Jin Yoo
Metabolites (2025) Vol. 15, Iss. 4, pp. 279-279
Open Access
Current landscape of dyslipidemia-related randomized clinical trials registered on the International Clinical Trials Registry Platform
Ling Pei, Ming Su, Reyihannisha Yakeya, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
Association between Lp(a) and T2D: A Mendelian Randomization Study
Marcin Goławski, Mateusz Lejawa, Maciej Banach, et al.
Archives of Medical Science (2024) Vol. 20, Iss. 3, pp. 1002-1005
Open Access | Times Cited: 3
Targeting PDGF/PDGFR Signaling Pathway by microRNA, lncRNA, and circRNA for Therapy of Vascular Diseases: A Narrow Review
Chaonan Ma, Shan-Rui Shi, Xueying Zhang, et al.
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1446-1446
Open Access | Times Cited: 3
Comparative Efficacy of β-Carotene and Losartan Against Isoproterenol-Induced Cardiac Fibrosis: An Experimental and Computational Studies
Niharika Patil, Vishal S. Patil, Nandeeni Punase, et al.
Journal of the American Nutrition Association (2025), pp. 1-16
Closed Access
The place of original pitavastatin in primary and secondary prevention of cardiovascular diseases. Interdisciplinary Expert Consensus of the Russian Society of Cardiology, the National Atherosclerosis Society, the Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention, and the Russian Association of Endocrinologists
М. Г. Бубнова, А. S. Galyavich, М. В. Ежов, et al.
Cardiosomatics (2025)
Open Access
Imaging approaches in risk stratification of patients with coronary artery disease: a narrative review
Gloria Santangelo, Elisa Gherbesi, L. Donisi, et al.
Archives of Medical Science (2024)
Open Access | Times Cited: 3
Alcohol, health loss and mortality: can wine really save the good name of moderate alcohol consumption?
Stanisław Surma, Grzegorz Gajos
Polskie Archiwum Medycyny Wewnętrznej (2024)
Open Access | Times Cited: 2
Inclisiran: the preclinical discovery and development of a novel therapy for the treatment of atherosclerosis
Donatos Tsamoulis, Lοukianos S. Rallidis, Constantine E. Kosmas
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 7, pp. 773-782
Closed Access | Times Cited: 2
It is Time to Address the Contribution of Cholesterol in all APOB-Containing Lipoproteins to Atherosclerotic Cardiovascular Disease
Peter P. Tóth, Maciej Banach
European Heart Journal Open (2024) Vol. 4, Iss. 4
Open Access | Times Cited: 2
Position paper of the Polish Expert Group on the use of pitavastatin in the treatment of lipid disorders in Poland endorsed by the Polish Lipid Association
Maciej Banach, Stanisław Surma, Agnieszka Kapłon‐Cieślicka, et al.
Archives of Medical Science (2023) Vol. 20, Iss. 1, pp. 28-42
Open Access | Times Cited: 5
A Nation-Wide Evaluation of Suboptimal Lipid-Lowering Treatment Patterns Among Patients Undergoing Intervention for Acute Coronary Syndrome in Hungary
G Nagy, László Márk, Andrea Gerencser, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6562-6562
Open Access | Times Cited: 1
Summary of 2023 and the biggest challenges for the “Archives of Medical Science” on its 20th Anniversary
Maciej Banach
Archives of Medical Science (2024) Vol. 20, Iss. 1, pp. 1-7
Open Access
Lipoprotein (a) and lipid-lowering treatment from the perspective of a cardiac surgeon. An impact on the prognosis in patients with aortic valve replacement and after heart transplantation
Stanisław Surma, Michał Zembala, Bogusław Okopień, et al.
International Journal of Cardiology Cardiovascular Risk and Prevention (2024) Vol. 22, pp. 200297-200297
Open Access
Page 1 - Next Page

Scroll to top